Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
In The Last Decade
doi.org/10.1086/514115 →Countries where authors are citing Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
This map shows the geographic impact of Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus more than expected).
Fields of papers citing Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
This network shows the impact of Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus.
About Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
This paper, published in 1997, received 513 indexed citations . Written by Syd Johnson, Cynthia N. Oliver, Gregory A. Prince, Val G. Hemming, David S. Pfarr, J. E. O'GRADY, Scott Koenig, James Tamura, Robert M. Woods and Geetha P. Bansal covering the research area of Epidemiology and Infectious Diseases. It is primarily cited by scholars working on Epidemiology (436 citations), Infectious Diseases (205 citations) and Pulmonary and Respiratory Medicine (185 citations). Published in The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1086/514115.